Skip to main content
Navigate Up
Sign In

Guidelines highlight ‘best practies’ for liquid biopsy during treatment of non-small cell lung cancer

“Liquid biopsy and its subsequent molecular analysis is a powerful tool that can determine the patient’s molecular tumor profile in order to determine the best therapeutic option and can be applied as an alternative to tissue testing in cases where tumor testing is not possible or tissue is not adequate,” said Fred R. Hirsch, professor of medicine and pathology at CU School of Medicine.